Search

Your search keyword '"Ortega-Castro R"' showing total 55 results

Search Constraints

Start Over You searched for: Author "Ortega-Castro R" Remove constraint Author: "Ortega-Castro R" Journal annals of the rheumatic diseases Remove constraint Journal: annals of the rheumatic diseases
55 results on '"Ortega-Castro R"'

Search Results

1. AB0416 SUBCUTANEUS VS INTRAVENOUS ABATACEPT IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS

2. AB0334 PREVALENCE AND ASSOCIATED FACTORS OF MULTIMORBIDITY IN PATIENTS WITH STABLISHED RHEUMATOID ARTHRITIS. DATA FROM THE CRHREAR REGISTRY

3. POS1142 SPANISH NATIONAL REGISTRY OF BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

4. POS0058 IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS

5. AB1149 EVALUATION OF THE EFFICACY AND SAFETY OF THE SARS-CoV-2 VACCINE IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH BIOLOGICAL THERAPY.

6. POS0907 ASSOCIATION BETWEEN DISEASE ACTIVITY AND DAMAGE IN IDIOPATHIC INFLAMMATORY MYOPATHIES. DIFFERENCES BETWEEN INCIDENT AND PREVALENT CASES

8. POS0465 UNSUPERVISED CLUSTERING ANALYSIS OF THE SERUM PROTEOME IDENTIFIES SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH DISTINCTIVE DISEASE SEVERITY AND LUPUS NEPHROPATHY

9. POS0327 IRISIN: A NEW MARKER OF SUBCLINICAL ATHEROSCLEROSIS, CARDIOVASCULAR RISK AND DISEASE ACTIVITY IN AXIAL SPONDYLOARTHRITIS?

10. AB0084 INCREASED LIVER DISEASE RISK IN RHEUMATOID ARTHRITIS IS ASSOCIATED WITH DISEASE ACTIVITY, INFLAMMATORY MARKERS, INSULIN RESISTANCE AND ACPAs. INFLUENCE OF METHOTREXATE

11. POS0440 THE ANALYSIS OF THE INFLAMMATORY PROTEOME IN RHEUMATOID ARTHRITIS IDENTIFIES COMMON SIGNATURES ASSOCIATED WITH THE CLINICAL RESPONSE TO DMARDs AND TNFi THERAPIES

12. OP0231 MASS CYTOMETRY DATA RECLASSIFY SYSTEMIC AUTOIMMUNE DISEASE PATIENTS IN PHENOTYPICALLY DISTINCTIVE GROUPS

14. POS0488 IDENTIFICATION OF NOVEL DISEASE BIOMARKERS IN SYSTEMIC SCLEROSIS THROUGH HIGH-THROUGHPUT PROTEOMICS

15. POS0211 PREDICTORS OF PROGRESSION AND MORTALITY IN PATIENTS WITH PREVALENT RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE: A PROSPECTIVE COHORT STUDY

18. POS0475 INTEGRATIVE CLINICAL, MOLECULAR AND COMPUTATIONAL ANALYSES ALLOW THE IDENTIFICATION OF DISTINCTIVE PHENOTYPES OF RHEUMATOID ARTHRITIS PATIENTS RELATED TO THE CLINICAL INVOLVEMENT AND THE RESPONSE TO TNF INHIBITORS

20. AB0070 ROLE OF VASPIN IN ATHEROSCLEROTIC DISEASE AND CARDIOVASCULAR RISK IN AXIAL SPONDYLOARTHRITIS

22. INFLUENCE OF INTERSTITIAL LUNG DISEASE DURATION ON THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS WITH ABATACEPT.

23. SAT0043 SERUM BIOMOLECULES AS POTENTIAL BIOMARKERS OF CLINICAL EFFICACY AND PREDICTORS OF RESPONSE TO BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS

24. AB0338 EVALUATION OF THE ASSOCIATION OF ALLELES OF INTOLERANCE RISK TO METOTREXATE IN RHEUMATOID ARTHRITIS PATIENTS UNDER TREATMENT WITH BIOLOGIC THERAPIES

25. FRI0316 CAN THE MOMENT OF OCCURRENCE OF THE FIRST EPISODE OF UVEITIS PREDICT DIFFERENCES IN THE PROGNOSIS OF SPONDYLOARTHRITIS? DATA FROM THE SPANISH REGISTRY REGISPONSER

26. SAT0373 QUANTITATIVE ASSESSMENT OF RESPONSIVENESS IN SACROILIAC JOINTS MRI OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS: A PILOT STUDY.

27. AB0136 THE SUSTAINED POSITIVITY FOR ANTI-DSDNA ANTIBODIES FOSTERS THE ESTABLISHMENT OF AN ATHEROTHROMBOTIC STATUS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

29. SAT0529 CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN A PATIENT GROUP WITH INTERSTITIAL LUNG DISEASE.

30. OP0137 GENOME-WIDE WHOLE-BLOOD TRANSCRIPTOME PROFILING IN A LARGE EUROPEAN COHORT OF SYSTEMIC SCLEROSIS PATIENTS

31. FRI0321 UTILITY OF THE ASAS HEALTH INDEX QUESTIONNAIRE AS A TOOL FOR HEALTH ASSESSMENT IN PATIENTS WITH SPONDYLOARTHRITIS AND ITS ASSOCIATION WITH DISEASE ACTIVITY, FUNCTIONALITY, MOBILITY, AND STRUCTURAL DAMAGE

34. INTEGRATED METABOLOMICS AND PROTEOMICS NETWORK ANALYSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS HIGHLIGHTS METABOLIC AND IMMUNITY PATHWAYS ASSOCIATED WITH DISTINCTIVE CLINICAL PROFILES.

35. LIPID METABOLISM IS DEEPLY ALTERED IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS AND REVERSED BY ANTI-TNF, ANTI-IL6R, AND JAK-INHIBITORS.

36. LONG-TERM FOLLOW UP OF ABATACEPT IN USUAL INTERSTITIAL PNEUMONIA ASSOCIATED TO RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 172 PATIENTS.

39. AB0116 Induction of Netosis-Mediated Cell Death in Ankylosing Spondylitis Patients

40. THU0152 Optimization Strategies of Biological Therapy in Rheumatoid Arthritis. Create Registry Results after Two Years of Follow-Up

41. AB0124 Peripheral Blood Mononuclear Cells from Ankylosing Spondylitis Patients Display An Atherogenic Profile Associated with Disease Activity and Endothelial Dysfunction

43. SAT0145 Long-Term Cost-Effectiveness Analysis of the Treatment with Infliximab, Etanercept and Adalimumab in Rheumatoid Arthritis Patients in Real-Life Clinical Practice

44. AB0478 Optimization of Biological Therapy in a Cohort of Patients with Rheumatoid Arthritis in HURS, CÓrdoba

46. AB0449 Is Cost-Effective Treating to Target of Remission in Established Rheumatoid Arthritis? Results of the Create Registry

50. UNBIASED HIERARCHICAL CLUSTERING OF CIRCULATING MOLECULAR PROFILES IN RHEUMATOID ARTHRITIS PATIENTS DEFINES PRECISE CV RISK. EFFECTS OF TNFI, IL6RI, AND JAKINIBS.

Catalog

Books, media, physical & digital resources